NeoFuragina 50mg 30 Tabs — Made in Poland by Teva — Free Delivery

NeoFuragina is an antibacterial preparation, a chemotherapeutic preparation, intended to be used to treat infections of the lower urinary tract. Intended for adults.

NeoFuragina contains the active ingredient furagin. Furagine (furazidine) is a chemotherapeutic preparation with a wide range of antibacterial activity. Due to its chemical structure, it belongs to the group of preparations called nitrofuran derivatives. It is used in the treatment and prevention of acute and chronic lower urinary tract infections (except those caused by Pseudomonas aeruginosa), including severe infections when the use of other antibacterial agents is ineffective. Furagin works in many ways, and the mechanism of its action is, inter alia, inhibiting the synthesis of bacterial proteins and damaging bacterial DNA. As a result, the process of bacterial multiplication is inhibited. Moreover, nitrofuran derivatives activate the body's immune system. The scope of the preparations action covers a number of Gram-positive and Gram-negative bacteria (also bacteria resistant to sulphonamides).

Active substance: furagin (Furaginum).

One tablet contains 50 mg of furagin.

Other ingredients: lactose monohydrate, potato starch, sucrose, polysorbate 80, stearic acid.

Adults:

- first day: 100 mg (2 tablets) 4 times a day;

- next days: 100 mg (2 tablets) 3 times a day.

Treatment usually lasts 7-8 days.

If during this time symptoms worsen or do not improve, consult your doctor.

If necessary, the treatment can be repeated after 10-15 days.

Method of preparation administration:

The tablets should be taken orally with meals containing protein (the protein increases the absorption of the preparation).

NeoFuragina is contraindicated in the case of:

- allergic to any component of the preparation or other nitrofuran derivatives;

- peripheral polyneuropathy (e.g. in the course of diabetes);

- renal failure (creatinine clearance less than 60 ml / min or increased levels of creatinine in the blood);

- glucose-6-phosphate dehydrogenase deficiency.

Do not use in children and adolescents, women in the first trimester of pregnancy.

Do not use from the 38th week of pregnancy and during childbirth.

Store at room temperature, out of reach of children.